Botanicals

Kemin and DSM commit to article 13.5 lutein submission

Kemin and DSM commit to article 13.5 lutein submission

By Shane Starling

Leading lutein suppler Kemin Health will resubmit a lutein dossier under article 13.5 of the European Union nutrition and health claims regulation, after EFSA last week rejected an article 13.1 lutein-eye health submission.

Supply: Beta-carotene club and beyond

Special Edition: Antioxidants

Supply: Beta-carotene club and beyond

By Jane Byrne

In the second part of our antioxidants special, NutraIngredients focuses on the carotenoids where the vitamin A converter, beta-carotene, is still lording it over lutein and lycopene and DSM and BASF’s synthetic versions continue to dominate that particular...

Overview: The (seemingly) unstoppable antioxidant powerhouse

Special edition: Antioxidants

Overview: The (seemingly) unstoppable antioxidant powerhouse

By Shane Starling

In the first instalment of this antioxidants special NutraIngredients scans a diverse global market that has barely been dented by the recession and continues to flourish amid consumer understanding that is often little more than surface deep.

Leatherhead chief backs health claim process

Leatherhead chief backs health claim process

By Shane Starling

Leatherhead Food Research chief executive, Dr Paul Berryman, tells Shane Starling that despite a swathe of European Food Safety Authority (EFSA) health claim rejections, the positive opinions that have come in offer much hope to industry.

Roadmaps to EU health claim success

Roadmaps to EU health claim success

By Shane Starling

As the European Union health claims climate evolves, companies are learning just what is required to demonstrate the benefits of healthy foods and supplements.

Markets: cranberry goes mainstream

Special Edition: Cranberries

Markets: cranberry goes mainstream

By Jane Byrne

In the first of a four part special edition focused on cranberries, NutraIngredients looks at the market for the berry, with its entrance into the indulgence sectors an indication perhaps that health positioning is no longer the sole driving force behind...

Naturex president: acquisition policy remains unchanged

Exclusive interview

Naturex president: acquisition policy remains unchanged

By Shane Starling

Naturex president and chief executive officer, Jacques Dikansky, tells Shane Starling why in August the French botanicals giant bought Spanish supplier, Natraceutical Group, to double its size for the third time since 2002.

Provexis enjoys fruits of health claims victory

Dispatches from FIE

Provexis enjoys fruits of health claims victory

Provexis chief executive officer, Stephen Moon tells Shane Starling why becoming the first company to achieve an article 13.5 proprietary health claim has been such a boon to his company.

Life in a European health claims wasteland

Life in a European health claims wasteland

Ka-CHING! Hear that? No it’s not the sound of overflowing cash registers as consumers throw endless wads of euros at scientifically-backed, healthy foods in greater numbers than ever before.

Follow us

Products

View more

Webinars